The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion ...

GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found.

GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found.

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, to a rare eye disease that may cause vision loss.

More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in their food and beverage preferences after starting the medication, a new study has claimed. The research ...

The report found that just over 2% of adults in the U.S. took a GLP-1 to treat obesity or overweight in 2024, up from just 0.3% in 2019. This is a relative increase of 586.7%, according to the ...

2. Among all adults with a GLP-1 prescription, the percentage of those diagnosed with obesity or overweight but not Type 2 diabetes increased from 3.7% in 2019 to 16.5% in 2024. 3.

Then She Revealed She Was on a GLP-1. After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1 By Megan Graham Share Resize ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...

EDITORIAL State health plan shortfall points to challenge of expensive weight loss drugs Group Insurance Commission will limit GLP-1 coverage. By The Editorial Board Updated May 21, 2025, 4:00 a.m.